Verapamil Hydrochloride Injection
Product Images NDC 23155-912

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 23155-912). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Avet Logo (Avet Logo)

FDA Label Image

Carton-25x2ml (Carton 25x2ml)

FDA Label Image

Carton-5x2ml (Carton 5x2ml)

FDA Label Image

Carton-5x4ml (Carton 5x4ml)

This is a description about a pharmaceutical product called VERAPAMIL HYDROCHLORIDE injection, USP. Each mL contains 2.5 mg of Verapamil Hydrochloride. It comes in single-dose vials of 4 mL with a concentration of 2.5 mg/mL. This medication is for intravenous use only and should be administered slowly over at least a two-minute period. The recommended storage temperature is between 20 to 25°C. The product should be protected from light and discarded if unused. For detailed dosage instructions, refer to the insert provided. The manufacturer is Avet Pharmaceuticals, Inc., with contact information in East Brunswick, NJ.*

FDA Label Image

Label-10mg-4ml (Label 10mg 4ml)

This text appears to be a label of Verapamil HCl (hydrochloride) intended for intravenous use. The medication is provided in a 4 mL single-dose vial. It is recommended to protect it from light and is manufactured in India by Avet Pharma. The revision date on the label is October 2024. Please consult the actual packaging or a healthcare professional for complete and accurate information.*

FDA Label Image

Label-5mg-2ml (Label 5mg 2ml)

This is a prescription medication called Verapamil HCI. It is an injection for intravenous use only, with a concentration of 5 mg/2 mL (2.5 mg/mL). The product is contained in a single-dose vial. The manufacturer is from India, and the medication should be protected from light. The expiration date is October 2024. The item number is 205000857.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.